W. Douglas Weaver
#159,295
Most Influential Person Now
W. Douglas Weaver's AcademicInfluence.com Rankings
W. Douglas Weavermedical Degrees
Medical
#3175
World Rank
#3630
Historical Rank
Cardiology
#323
World Rank
#333
Historical Rank
Download Badge
Medical
Why Is W. Douglas Weaver Influential?
(Suggest an Edit or Addition)W. Douglas Weaver's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). (1996) (1525)
- ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). (1996) (1335)
- Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. (1995) (1025)
- Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. (2000) (999)
- Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. (1999) (897)
- Acute Coronary Care in the Elderly, Part I. Non–ST-Segment–Elevation Acute Coronary Syndromes: A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology (2007) (859)
- Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review (1997) (802)
- 1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) (1999) (737)
- Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial. (1993) (682)
- Confirmation of a heart failure epidemic: findings from the Resource Utilization Among Congestive Heart Failure (REACH) study. (2002) (575)
- Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. (1994) (515)
- Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention: A Platelet Inhibition and Patient Outcomes (PLATO) Trial Subgroup Analysis (2010) (478)
- Darapladib for preventing ischemic events in stable coronary heart disease. (2014) (475)
- Acute Coronary Care in the Elderly, Part II: ST-Segment–Elevation Myocardial Infarction A Scientific Statement for Healthcare Professionals From the American Heart Association Council on Clinical Cardiology (2007) (421)
- ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). (1996) (409)
- A randomized trial of transfer for primary angioplasty versus on-site thrombolysis in patients with high-risk myocardial infarction: the Air Primary Angioplasty in Myocardial Infarction study. (2002) (384)
- Appropriateness of percutaneous coronary intervention. (2011) (378)
- Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial (2003) (375)
- Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators. (1996) (358)
- International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
- Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry. (1992) (350)
- Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction: The COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) Trial (2003) (346)
- Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. (1998) (346)
- Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. (1995) (341)
- TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. (1998) (335)
- Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1995) (333)
- Use of reperfusion therapy for acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2. (1998) (329)
- Comparison of presentation, treatment, and outcome of acute myocardial infarction in men versus women (the Myocardial Infarction Triage and Intervention Registry) (1996) (328)
- A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. (1996) (328)
- A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators. (1996) (317)
- ACCF/SCAI/STS/MTS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization. Commentary (2009) (310)
- Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. (1996) (300)
- Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial. (2014) (288)
- ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El (2006) (282)
- Trends in reperfusion strategies, door-to-needle and door-to-balloon times, and in-hospital mortality among patients with ST-segment elevation myocardial infarction enrolled in the National Registry of Myocardial Infarction from 1990 to 2006. (2008) (281)
- Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators. (1996) (271)
- Clinical characteristics and outcome of patients with early ( 4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. (2002) (263)
- Myocardial Infarction Triage and Intervention Project--phase I: patient characteristics and feasibility of prehospital initiation of thrombolytic therapy. (1990) (263)
- The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. (1993) (245)
- The prehospital electrocardiogram in acute myocardial infarction: is its full potential being realized? National Registry of Myocardial Infarction 2 Investigators. (1997) (241)
- Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial. (2006) (225)
- Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. (2003) (221)
- Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. (1996) (217)
- Time delays in the diagnosis and treatment of acute myocardial infarction: a tale of eight cities. Report from the Pre-hospital Study Group and the Cincinnati Heart Project. (1990) (204)
- Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. (2006) (203)
- Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. The MITI Project Group. (1991) (201)
- Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. (2006) (200)
- The Physician's Role in Minimizing Prehospital Delay in Patients at High Risk for Acute Myocardial Infarction: Recommendations from the National Heart Attack Alert Program (1997) (194)
- Effect of Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Fibrinolysis in Acute Myocardial Infarction: The COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) Trial (2003) (193)
- ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El (2006) (175)
- Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction. (1996) (171)
- Utility of the prehospital electrocardiogram in diagnosing acute coronary syndromes: the Myocardial Infarction Triage and Intervention (MITI) Project. (1998) (164)
- Time to thrombolytic treatment: factors affecting delay and their influence on outcome. (1995) (162)
- Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. (2002) (160)
- Angiotensin-converting enzyme inhibitors in coronary artery disease and preserved left ventricular systolic function: a systematic review and meta-analysis of randomized controlled trials. (2006) (159)
- Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries. (1999) (156)
- An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry. (2004) (154)
- Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry). (2013) (154)
- Gender and acute myocardial infarction: is there a different response to thrombolysis? (1997) (151)
- Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. (2000) (150)
- Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial. (2009) (149)
- Myocardial imaging with intravenously injected thallium-201 in patients with suspected coronary artery disease: analysis of technique and correlation with electrocardiographic, coronary anatomic and ventriculographic findings. (1977) (146)
- Inflammatory Biomarkers Interleukin‐6 and C‐Reactive Protein and Outcomes in Stable Coronary Heart Disease: Experiences From the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial (2017) (144)
- Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. (2002) (141)
- Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. (1996) (138)
- Socioeconomic Status Is an Important Determinant of the Use of Invasive Procedures After Acute Myocardial Infarction in New York State (2000) (133)
- Accuracy of computer-interpreted electrocardiography in selecting patients for thrombolytic therapy. MITI Project Investigators. (1991) (126)
- EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention. (2016) (125)
- Factors influencing the time to thrombolysis in acute myocardial infarction. Time to Thrombolysis Substudy of the National Registry of Myocardial Infarction-1. (1997) (123)
- International variation in and factors associated with hospital readmission after myocardial infarction. (2012) (122)
- Misdiagnosis of atrial fibrillation and its clinical consequences. (2004) (120)
- Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. (2005) (117)
- Comparison of Clinical Interpretation With Visual Assessment and Quantitative Coronary Angiography in Patients Undergoing Percutaneous Coronary Intervention in Contemporary Practice: The Assessing Angiography (A2) Project (2013) (117)
- Association of gender and survival in patients with acute myocardial infarction. (1997) (114)
- Mortality and Morbidity Remain High Despite Captopril and/or Valsartan Therapy in Elderly Patients With Left Ventricular Systolic Dysfunction, Heart Failure, or Both After Acute Myocardial Infarction: Results From the Valsartan in Acute Myocardial Infarction Trial (VALIANT) (2005) (107)
- Optimum percutaneous transluminal coronary angioplasty compared with routine stent strategy trial (OPUS-1): a randomised trial (2000) (105)
- The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention (2013) (102)
- Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1998) (101)
- ST-segment elevation myocardial infarction: recommendations on triage of patients to heart attack centers: is it time for a national policy for the treatment of ST-segment elevation myocardial infarction? (2006) (100)
- Early Statin Initiation and Outcomes in Patients With Acute Coronary Syndromes (2002) (92)
- Report of the American Heart Association Task Force on the Future of Cardiopulmonary Resuscitation. (1992) (92)
- A meta-analysis of randomized control trials comparing minimally invasive direct coronary bypass grafting versus percutaneous coronary intervention for stenosis of the proximal left anterior descending artery. (2007) (89)
- Patient-Specific Predictions of Outcomes in Myocardial Infarction for Real-Time Emergency Use: A Thrombolytic Predictive Instrument (1997) (88)
- Hospital mortality in acute myocardial infarction in the era of reperfusion therapy (the Myocardial Infarction Triage and Intervention Project). (1993) (85)
- Factors influencing the time to administration of thrombolytic therapy with recombinant tissue plasminogen activator (data from the National Registry of Myocardial Infarction). Participants in the National Registry of Myocardial Infarction. (1995) (83)
- Selection of thrombolytic therapy for individual patients: development of a clinical model. GUSTO-I Investigators. (1997) (82)
- Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. (1998) (80)
- Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary interventi (2013) (80)
- Influence of early prehospital thrombolysis on mortality and event-free survival (the Myocardial Infarction Triage and Intervention [MITI] Randomized Trial). MITI Project Investigators. (1996) (78)
- Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries. (2002) (77)
- Early statin initiation and outcomes in patients with acute coronary syndromes. (2002) (76)
- The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry. (2006) (75)
- An approach to shorten time to infarct artery patency in patients with ST-segment elevation myocardial infarction. (2007) (72)
- Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. (1996) (71)
- Preliminary experience with intravenous P2Y12 platelet receptor inhibition as an adjunct to reduced-dose alteplase during acute myocardial infarction: results of the Safety, Tolerability and Effect on Patency in Acute Myocardial Infarction (STEP-AMI) angiographic trial. (2007) (68)
- Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. (1997) (68)
- Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy (2018) (67)
- Enzyme estimates of infarct size correlate with functional and clinical outcomes in the setting of ST-segment elevation myocardial infarction (2005) (66)
- Long-term Outcome in Acute Myocardial Infarction Patients Admitted to Hospitals With and Without On-site Cardiac Catheterization Facilities (1997) (66)
- Prasugrel Plus Aspirin Beyond 12 Months Is Associated With Improved Outcomes After Taxus Liberté Paclitaxel-Eluting Coronary Stent Placement (2015) (64)
- Sequential combination thrombolytic therapy for acute myocardial infarction: results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial. (1995) (64)
- Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. (1998) (57)
- The prognostic significance of serial myoglobin, troponin I, and creatine kinase-MB measurements in patients evaluated in the emergency department for acute coronary syndrome. (2003) (56)
- Bundle branch block patterns, age, renal dysfunction, and heart failure mortality. (2005) (56)
- Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes. (2004) (55)
- Length of hospital stay after acute myocardial infarction in the Myocardial Infarction Triage and Intervention (MITI) Project registry. (1996) (55)
- Early angiography versus conservative treatment in patients with non-ST elevation acute myocardial infarction: MITI Investigators. Myocardial Infarction Triage and Intervention. (2000) (54)
- Appearance of abnormal Q waves early in the course of acute myocardial infarction: implications for efficacy of thrombolytic therapy. (1995) (54)
- An electrocardiographic acuteness score for quantifying the timing of a myocardial infarction to guide decisions regarding reperfusion therapy. (1995) (53)
- Performance of multiple cardiac biomarkers measured in the emergency department in patients with chronic kidney disease and chest pain. (2002) (52)
- 31st Bethesda Conference. Emergency Cardiac Care. Task force 2: Acute coronary syndromes: Section 2A--Prehospital issues. (2000) (48)
- Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators. Myocardial Infarction Triage and Intervention. (1995) (48)
- Development of systems of care for ST-elevation myocardial infarction patients: the primary percutaneous coronary intervention (ST-elevation myocardial infarction-receiving) hospital perspective. (2007) (48)
- Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study. (2013) (47)
- Recent changes in management of acute myocardial infarction: implications for emergency care physicians. (1988) (47)
- Diabetes Mellitus and Prevention of Late Myocardial Infarction After Coronary Stenting in the Randomized Dual Antiplatelet Therapy Study (2016) (45)
- Use and accuracy of state death certificates for classification of sudden cardiac deaths in high-risk populations. (1997) (45)
- Transcutaneous ultrasound-facilitated coronary thrombolysis during acute myocardial infarction. (2003) (44)
- Prevalence and management of hypertension in acute coronary syndrome patients varies by sex: observations from the Sibrafiban versus aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes (SYMPHONY) randomized clinical trials. (2005) (43)
- Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. (1999) (41)
- Underuse of invasive procedures among Medicaid patients with acute myocardial infarction. (2001) (40)
- Emergency evaluation of chest pain in patients with advanced kidney disease. (2002) (39)
- Lipoprotein‐Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease (2016) (38)
- Relation of age and race with hospital death after acute myocardial infarction. (2004) (38)
- A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). (2000) (36)
- New recombinant glycosylated prourokinase for treatment of patients with acute myocardial infarction. Prourokinase Study Group. (1994) (36)
- Combined historical and electrocardiographic timing of acute anterior and inferior myocardial infarcts for prediction of reperfusion achievable size limitation. (1999) (35)
- Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Myocardial Infarction Triage and Intervention Investigators. (1996) (35)
- All hospitals are not equal for treatment of patients with acute myocardial infarction. (2003) (34)
- Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial). (2005) (34)
- Long-Term Follow-Up of Gender-Specific Outcomes After Thrombolytic Therapy for Acute Myocardial Infarction from the GUSTO-I Trial (1997) (32)
- The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy-facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized clinical trials. (2007) (30)
- Reperfusion therapy in patients with acute myocardial infarction and prior coronary artery bypass graft surgery (National Registry of Myocardial Infarction-2). (1999) (30)
- Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. (1999) (30)
- Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators. (1999) (30)
- Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. (1997) (29)
- The role of thrombolytic drugs in the management of myocardial infarction. Comparative clinical trials. (1996) (29)
- N-terminal pro-brain natriuretic peptide and the timing, extent and mortality in ST elevation myocardial infarction. (2006) (28)
- Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome. (2017) (28)
- Mortality Implications of Primary Percutaneous Coronary Intervention Treatment Delays: Insights From the Assessment of Pexelizumab in Acute Myocardial Infarction Trial (2011) (28)
- The impact of extreme-risk cases on hospitals' risk-adjusted percutaneous coronary intervention mortality ratings. (2015) (27)
- Underutilization of reperfusion therapy in eligible African Americans with acute myocardial infarction: Role of presentation and evaluation characteristics. (2001) (27)
- Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomes. (2016) (26)
- Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction (1998) (26)
- Long-term implications of racial differences in the use of revascularization procedures (the Myocardial Infarction Triage and Intervention registry). (1997) (26)
- Estimating the proportion of post-myocardial infarction patients who may benefit from prophylactic implantable defibrillator placement from analysis of the CAST registry. Cardiac Arrhythmia Suppression Trial. (1998) (26)
- Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). (2004) (26)
- The influence of clinical risk factors on the use of angiography and revascularization after acute myocardial infarction. Myocardial Infarction Triage and Intervention Project Investigators. (1995) (24)
- Higher T-wave amplitude associated with better prognosis in patients receiving thrombolytic therapy for acute myocardial infarction (a GUSTO-I substudy). Global Utilization of Streptokinase and Tissue plasminogen Activator for Occluded Coronary Arteries. (1998) (24)
- The dilemma of sensitivity versus specificity in computer-interpreted acute myocardial infarction. (1992) (24)
- Potential use of thrombolytic therapy before hospitalization. (1989) (24)
- Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. (2006) (23)
- Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators. (1999) (23)
- Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial. (2010) (22)
- Electrocardiographic phasing of acute myocardial infarction. (1992) (22)
- Hospital protocols and policies that may delay early identification and thrombolytic therapy of acute myocardial infarction patients (2004) (21)
- Current status of preventive cardiology training among United States cardiology fellowships and comparison to training guidelines. (2012) (21)
- Evaluating the Generalizability of a Large Streamlined Cardiovascular Trial: Comparing Hospitals and Patients in the Dual Antiplatelet Therapy Study Versus the National Cardiovascular Data Registry (2015) (20)
- Admission prediction of expected final myocardial infarct size using weighted ST-segment, Q wave, and T wave measurements. (1997) (20)
- Influence of External Defibrillator Electrode Polarity on Cardiac Resuscitation (1993) (20)
- Concerning the mechanism of pexelizumab's benefit in acute myocardial infarction. (2006) (20)
- Transfer Times and Outcomes in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Interhospital Transfer for Primary Percutaneous Coronary Intervention: APEX-AMI Insights (2012) (20)
- Health care delivery system reform: accountable care organizations. (2009) (20)
- Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction. (1996) (18)
- Primary coronary angioplasty in hospitals with and without surgery backup. MITI project investigators. (1995) (17)
- "Major" Depressive Disorder, coronary heart disease, and the DSM-IV threshold problem. (2006) (17)
- Racial analysis of patients with myocardial infarction complicated by heart failure and/or left ventricular dysfunction treated with valsartan, captopril, or both. (2008) (17)
- Sex and outcome after myocardial infarction: A case of sexual politics? (2000) (17)
- Is onsite surgery backup necessary for percutaneous coronary interventions? (2004) (16)
- Rest and exercise myocardial imaging with thallium-201-correlation with EKG, coronary anatomy, and left ventricular function (1976) (16)
- Time-dependent predictors of primary cardiac arrest in patients with acute myocardial infarction. (2003) (15)
- Single lead ST-segment recovery: a simple, reliable measure of successful fibrinolysis after acute myocardial infarction. (2004) (15)
- Patient selection for thrombolytic therapy: Emergency physician versus electrocardiographer (1990) (15)
- Factors associated with rehospitalization in patients with acute myocardial infarction. (1997) (15)
- Interleukin‐18 in patients with acute coronary syndromes (2019) (14)
- Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities. MITI Investigators. Myocardial Infarction Triage and Intervention. (1997) (13)
- President's page: antimicrobial prophylaxis to prevent infective endocarditis: why did the recommendations change? (2008) (13)
- ECG findings in acute myocardial infarction. Are there sex-related differences? (1995) (12)
- Resource utilization, cost, and health status impacts of coronary stent versus "optimal" percutaneous coronary angioplasty: results from the OPUS-I trial. (2002) (11)
- Randomized, controlled trial of RheothRx (poloxamer 188) in patients with suspected acute myocardial infarction. RheothRx in Myocardial Infarction Study Group. (1998) (11)
- Reperfusion therapy after pre-hospital cardiac arrest and its influence on outcome after acute myocardial infarction (1996) (11)
- Identification of Hospital Outliers in Bleeding Complications After Percutaneous Coronary Intervention (2015) (11)
- Combination therapy for acute myocardial infarction. (1999) (11)
- The Exclusion of Women from Clinical Trials of Thrombolytic Therapy (1995) (10)
- Cardiology clinical trial participation in community-based healthcare systems: obstacles and opportunities. (2008) (10)
- 715-5 Reteplase vs Alteplase Patency Investigation During Myocardial Infarction Trial (RAPID 2) (1995) (10)
- The potential for prehospital thrombolytic therapy. (1990) (10)
- Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis). (2001) (9)
- Myocardial imaging and radionuclide angiography in survivors of sudden cardiac death due to to ventricular fibrillation: preliminary report. (1977) (8)
- Variability of acute ST-segment predicted myocardial infarct size in the absence of thrombolytic therapy. (1994) (8)
- Reducing cardiac events after acute coronary syndromes. (2004) (8)
- Outcomes in African-American women with suspected acute myocardial infarction: the Myocardial Infarction Triage and Intervention Project. (1995) (8)
- Treating myocardial infarction: importance of early reperfusion (1994) (7)
- A comparison of the treatment of acute myocardial infarction between St. Petersburg, Russia and Seattle, Washington. (1996) (7)
- Streamlining the triage system for acute myocardial infarction. (1995) (7)
- Professional accountability in health system reform. (2009) (7)
- Clinical trial results with a new plasminogen activator. (1997) (7)
- Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial). (2016) (7)
- Clinical studies with the new glycosylated recombinant prourokinase. (1995) (7)
- Active Lipid Management In Coronary Artery Disease (ALMICAD) study. (2007) (7)
- A Naturally Randomized Trial Comparing the Effect of Long ‐ term Exposure to Low LDL ‐ C , Low SBP , or Both on the Risk of Cardiovascular Disease (2017) (6)
- Long-term outcomes based on time-to-angioplasty in patients admitted with non-ST-segment elevation acute coronary syndromes. (2005) (6)
- Cost analysis of endovenous catheter ablation versus surgical stripping for treatment of superficial venous insufficiency and varicose vein disease. (2014) (6)
- President's page: drug-eluting stents in contemporary practice--a call for a real-world, open-entry, device-tracking registry. (2007) (5)
- Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute Myocardial Infarction Treated With Thrombolysis: Results from GUSTO-I : Results From Gusto-I (1998) (5)
- Primary Angioplasty for Acute Myocardial Infarction at Hospitals With No Surgery On-Site: The Prospective Multicenter PAMI-No SOS Registry (1998) (5)
- Heart failure and/or left ventricular systolic dysfunction complicating myocardial infarction is common and accounts for the majority of in-hospital myocardial infarction mortality: Results of the VALIANT registry (2003) (5)
- Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes. (2005) (4)
- 1061-95 Effect of therapeutic transcutaneous ultrasound following thrombolysis: Results of the perfusion by thrombolytic and ultrasound (PLUS) trial (2004) (4)
- Why we should not do percutaneous coronary intervention at sites without surgical backup (2005) (4)
- Infarct size: thrombolysis versus PTCA. (1999) (4)
- Improving outcomes in patients undergoing primary angioplasty for acute myocardial infarction: trend data from the National Registry of Myocardial Infarction 2 (1998) (4)
- Coronary Heart Disease Ticagrelor Versus Clopidogrel in Patients With ST-Elevation Acute Coronary Syndromes Intended for Reperfusion With Primary Percutaneous Coronary Intervention (2010) (4)
- President's page: The continuing importance of international engagement. (2008) (4)
- Computerized electrocardiography for selection of patients for prehospital initiated thrombolysis. (1992) (3)
- Working group 7: Enhancing the job "matching" process. (2004) (3)
- Prehospital treatment of myocardial infarction. (1995) (3)
- Use of Helicopter Transportation in Acute Myocardial Infarction in the United States (1998) (3)
- Sex and Outcome After Myocardial Infarction (2000) (3)
- Dyslipidemia in patients with angiographically confirmed coronary artery disease—an opportunity for improvement (2004) (3)
- Early triage and treatment of the acute myocardial infarction patient: how fast is fast? (1990) (3)
- Diagnostic parameters of CK-MB and myoglobin related to chest pain duration. (2002) (3)
- 1118-101 Congestive Heart Failure and Cardiogenic Shock Complicating Acute Myocardial Infarction Have High Mortality and Are Associated With Intense Inflammatory Response: Results From the CARDINAL Trials (2004) (3)
- Does enrollment in a randomized clinical trial lead to a higher cost of routine care? (2002) (3)
- Relation of time to treatment on relative effects of primary coronary angioplasty vs thrombolytic therapy (2000) (3)
- Acute myocardial infarction and prior coronary artery surgery in the Myocardial Infarction Triage and Intervention Registry: Patient characteristics, treatment, and outcome (1991) (3)
- APPROPRIATENESS OF PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES: INSIGHTS FROM THE NCDR CATH/PCI REGISTRY (2011) (3)
- The role of appropriate use criteria for coronary revascularization. (2009) (2)
- Early patency of the infarct-related artery after myocardial infarction preserves diastolic filling. (2001) (2)
- DO EXTREME RISK CASES IMPACT HOSPITALS' RISK-ADJUSTED PCI MORTALITY RATINGS? RESULTS FROM THE NCDR® (2012) (2)
- Early recognition and treatment of the patient suffering from acute myocardial infarction. A description of the Myocardial Infarction Triage and Intervention Project. (1990) (2)
- 791-3 The Influence of Clinical Risk Factors on the Use of Angiography and Revascularization After Acute Myocardial Infarction (1995) (2)
- Effect of Darapladib onMajor Coronary Events After an Acute Coronary Syndrome The SOLID-TIMI 52 Randomized Clinical Trial (2014) (2)
- Which patients with left ventricular dysfunction require chronic anticoagulation? A prospective analysis (1998) (2)
- Prehospital thrombolysis in myocardial infarction. (1994) (2)
- President's page: Carrying our message on quality and reform forward. (2009) (2)
- President's page: disclosures, transparency, and firewalls protect integrity. (2008) (2)
- The role of Appropriate use Criteria for coronary revascularization (2009) (2)
- President's page: expanding our diversity to expand our reach. (2008) (2)
- President's Page: Henry D. McIntosh: a life story that should guide us as physicians. (2009) (1)
- Performance of cardiac troponin I in the exclusion of myocardial infarction in patients with advanced renal disease (2002) (1)
- TNK–Tissue Plasminogen Activator Compared With Front-Loaded Alteplase in Acute Myocardial Infarction Results of the TIMI 10B Trial Clinical Investigation and Reports (1998) (1)
- Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy for Myocardial Infarction-Reply (1994) (1)
- President's page: quality begins first with personal responsibility. (2008) (1)
- Prehospital Thrombolysis: The impact of Very Early Therapy on Acute Myocardial Infarction (1994) (1)
- Use of thrombolytic therapy in the elderly: Results from the myocardial infarction, triage and intervention project (1990) (1)
- President's page: understanding the implications of conflict of interest issues. (2008) (1)
- Facilitated angioplasty with combined ADP P2T receptor blockade and fibrinolysis for the treatment of acute myocardial infarction: results from the STEP-AMI trial (2002) (1)
- Abstract 5133: Does Public Smoking Ban Reduce the Incidence of Myocardial Infarction in Michigan? A Systematic Review and Attributable Risk Analysis (2008) (1)
- President's Page: The Train (2009) (1)
- Abstract 569: NT-proBNP is an Important Independent Predictor of Clinical Events after Primary PCI for STEMI (2008) (1)
- Long-term outcomes based on time-to-angiography in patients admitted with non-ST-segment elevation acute coronary syndromes (2005) (1)
- Abstract 12833: Hospital Variation in Bleeding Complications Following Percutaneous Coronary Intervention (PCI): Results from the National Cardiovascular Data Registry (NCDR) (2011) (1)
- State death certificates can be used to identify cases of sudden cardiac death (1996) (1)
- CURRENT STATUS OF PREVENTIVE CARDIOLOGY TRAINING AMONG UNITED STATES CARDIOLOGY FELLOWSHIPS: ADHERENCE TO TRAINING GUIDELINES (2011) (1)
- Abstract 18092: The Relationship Between Patency of the Culprit Artery on Admission and Electrolyte Changes in Anterior STEMI - Analysis From the EMBRACE STEMI Clinical Trial (2016) (0)
- ·P-44 A microcomputer-based patient tracking system (1990) (0)
- Low-energy impedance-compensating biphasic waveforms defibrillate pre-hospital ventricular fibrillation at high rates (1998) (0)
- Abstract 9351: Are “All-Comer” Clinical Trials Representative of Contemporary Clinical Practice: A Linked Analysis of the Dual Antiplatelet Therapy (DAPT) Study and the National Cardiovascular Data Registry® (2013) (0)
- 725-2 Long Term Outcome After Early Prehospital Initiated Thrombolysis (1995) (0)
- Mitral valve prolapse: its recognition and nursing implications. (1981) (0)
- Waiting for GUSTO: current status of thrombolytic therapy. Medical panel discussion (1993) (0)
- T-Segment Elevation Myocardial nfarction : Recommendations on riage of Patients to Heart Attack Centers s it Time for a National Policy for the reatment of ST-Segment Elevation Myocardial Infarction ? (2006) (0)
- BIOMARKERS FOR PREDICTION OF OUTCOMES IN REVASCULARIZED PATIENTS WITH NON-ST-ELEVATION ACUTE CORONARY SYNDROME: A PLATO SUBSTUDY (2014) (0)
- Should community hospitals perform angioplasty for acute myocardial infarction? (1996) (0)
- Glucose, insulin, and acute myocardial infarction: reply (2006) (0)
- Higher T-Wave Amplitude Associated With Better Prognosis in Patients Receiving Thrombolytic Therapy for Acute Myocardial Infarction (a GUSTO-I Substudy) 11This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California (1998) (0)
- Abstract P84: The Impact of a Potential Nationwide Comprehensive Smoking Ban on Acute Myocardial Infarction Hospitalizations (2011) (0)
- The prognostic significance of myoglobin in the emergency department in patients with chest pain (2002) (0)
- Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents : Primary Endpoint Results from the Dual Antiplatelet Therapy Study (2014) (0)
- Interview with W. Douglas Weaver, MD (1995) (0)
- President's page: taking up the challenge and continuing the charge. (2008) (0)
- Patients transferred for primary PCI in APEX-AMI (Assessment of pexelizumab in acute myocardial infarction) trial have only modest symptom onset to PCI delays and good outcomes (2007) (0)
- Reply to Takagi et al. (2007) (0)
- Risk factors for ischemic stroke in patients with acute myocardial infarction treated with thrombolytic therapy (1996) (0)
- President’s Page: The American College of Cardiology’s Continuing Support for Interventional Cardiology (2007) (0)
- 2 Bleeding Risk : The Dark Side of Anticoagulant Drugs (0)
- The forum: Dedicated to the discussion of Institute affairs (1913) (0)
- Effect of cardiac history upon the accuracy of acute myocardial infarction diagnosis by electrocardiogram in candidates for out-of-hospital thrombolysis (1990) (0)
- Very early serial electrocardiography in acute myocardial infarction Can early be too soon (1993) (0)
- THE ASSOCIATION BETWEEN LEFT VENTRICULAR MASS AND MEASURES OF INFARCT SIZE IN ANTERIOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE EMBRACE STEMI CLINICAL TRIAL (2016) (0)
- MYOCARDIAL INFARCTION The Prehospital Electrocardiogram in Acute Myocardial Infarction: Is Its Full Potential Being Realized? (2016) (0)
- COLLABORATION-WORKING TOGETHER TO IMPROVE THE CARE OF OUR PATIENTS (2012) (0)
- 755-6 Neurosurgical Evacuation for Intracranial Hemorrhage Associated with Improved Outcome in GUSTO (1995) (0)
- Admission glucose, baseline glucose control, and mortality after acute myocardial infarction in diabetic patients (2003) (0)
- 1118-102 Baseline white blood cell count and interleukin-6 levels provide complementary prognostic information in acute myocardial infarction: Results from the CARDINAL trial (2004) (0)
- OPUS and routine angiography (2000) (0)
- President's Page: ACC.09 and i2 Summit: Meeting Your MOC and Core Learning Needs (2008) (0)
- Abstracts of Original Contributions: 45th Annual Scientific Session (1996) (0)
- Provisional versus routine coronary stenting. A review. (2001) (0)
- 2 Circ Cardiovasc Qual Outcomes January 2015 metric in the Centers for Medicare and Medicaid Services Acute Care Episode (0)
- The impact of chronic renal insufficiency on heart failure mortality after hospitalization (1999) (0)
- Body Mass Index, Functional Status and Survival in Patients with Heart Failure: 660 (2006) (0)
- 1023-95 Excessive bleeding with aspirin, clopidogrel, and warfarin “Triple Therapy” (2004) (0)
- Response to letters regarding article, "comparison of clinical interpretation with visual assessment and quantitative coronary angiography in patients undergoing percutaneous coronary intervention in contemporary practice: the assessing angiography (A2) project". (2013) (0)
- New onset atrial fibrillation following myocardial infarction is a strong independent predictor of mortality in patients treated with primary percutaneous coronary intervention (2008) (0)
- Importance of Q waves on the initial ECG in patients considered for thrombolytic therapy (1991) (0)
- Coronary Artery Disease Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2006) (0)
- Prior coronary artery surgery and acute myocardial infarction: Patient characteristics, treatment, and outcome (1991) (0)
- Characteristics of myocardial infarction episodes in two distant communities: From the REGICOR registry in Girona, Spain and the MITI registry in Greater Seattle, USA (1994) (0)
- Body Mass Index, Functional Status and Survival in Patients with Heart Failure: 660 1:15 PM – 1:30 PM (2006) (0)
- Mechanical Reperfusion Strategies in Patients Presenting with Acute Myocardial Infarction (2007) (0)
- The Western Washington and Myocardial Infarction Triage and Intervention Trials of Thrombolytic Therapy: 15 Years of Collaboration in the Pacific Northwest (1997) (0)
- Response to letters regarding article, "prasugrel plus aspirin beyond 12 months is associated with improved outcomes after TAXUS Liberté paclitaxel-eluting coronary stent placement". (2015) (0)
- Acute myocardial infraction―Seattle 1990 (1991) (0)
- Hospital mortality in acute myocardial infarction-1989 (1990) (0)
- The effect of age on early death and stroke rates in patients with heart failure after acute myocardial infarction (2003) (0)
- Pharmacological interventions for acute myocardial infarction (2003) (0)
- Changes in the use of thrombolytic therapy in Seattle area hospitals from 1988 to 1992: Results from the myocardial infarction triage and intervention registry (2005) (0)
- Poverty and mortality in patients with acute coronary syndromes: a search for answers and a call for action. (2003) (0)
- The rate of ischemic stroke following acute myocardial infarction is decreasing. The national registry of myocardial infarction experience (1998) (0)
- Trial of Prehosptial Thrombolysis for Acute Myocardial Infarction: Is Sooner Necessarily Better? (1994) (0)
- Prehospital monitoring of patients with possible acute coronary thrombosis (1988) (0)
- Novel Tissue Plasminogen Activators: Reteplase (R-PA) (1997) (0)
- Thrombolytic therapy after GUSTO: medical roundtable. Discussion (1994) (0)
- Abstract 21: Transfer Times and Outcomes in ST-Elevations Myocardial Infarction Patients Undergoing Inter-Hospital Transfer for Primary Percutaneous Coronary Intervention: APEX-AMI Insights (2012) (0)
- Initial hypotension in acute myocardial infarction: Patient characteristics, treatment, and outcome (1991) (0)
- President's page: Subspecialty societies, subspecialists, and the ACC: building a unified effort. (2008) (0)
- Myocardial Infarction Treated With Thrombolysis : Results From GUSTO-I Risk Factors for In-hospital Nonhemorrhagic Stroke in Patients With Acute (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With W. Douglas Weaver?
W. Douglas Weaver is affiliated with the following schools:
